Reference

Analytical determination of dipyridamole

Analytical determination of dipyridamole. Chemical, gravimetric, and redoximetric methods for determination. Popa, Crina-Maria; Morait, G. (Lab. Chim. Anal., Fac. Farm., Bucharest, Rom.). Farmacia (Bucharest), 34(3), 159-66 (Romanian) 1986. CODEN: FRMBAZ. ISSN: 0014-8237. 1343-93-7 and 12027-38-2 are cas registry numbers of chemicals which are used as reagents here. DOCUMENT TYPE: Journal CA Section: 64 (Pharmaceutical Analysis) Dipyridamole [58-32-2] may be detd. gravimetrically in pharmaceutical forms by pptn. with tetrahydrogen dodecatungstosilicate [12027-38-2], trihydrogen dodecatungstophosphate [1343-93-7], tetrahydrogen dodecamolybdosilicate [12027-12-2], or trihydrogen dodecamolybdophosphate [12026-57-2]. A ceriometric (redoximetric) method for detn. of the drug in injectable prepns. is also described. .

The effect of dipyridamole on platelet function: correlation with blood levels in man

The effect of dipyridamole on platelet function: correlation with blood levels in man. Rajah, S. M.; Crow, M. J.; Penny, A. F.; Ahmad, R.; Watson, D. A. (Leeds Reg. Thor. Surg. Cent., Killingbech Hosp., Leeds/Yorkshire, Engl.). Br. J. Clin. Pharmacol., 4(2), 129-33 (English) 1977. CODEN: BCPHBM. DOCUMENT TYPE: Journal CA Section: 1 (Pharmacodynamics) The effect on platelet functions of dipyridamole (I) [58-32-2] was compared with a control group of patients taking warfarin. Adhesion, aggregation and platelet factor 4 availability decreased in the I group. Aggregation and platelet factor 4 were correlated with blood I. Adhesion, aggregation, and platelet factor 4 were decreased below the lower limit of normal at blood I levels above 3.5 .mu.mol/L.